Hospira to buy some Orchid biz for $400 mn

Hospira to buy some Orchid biz for $400 mn

New Delhi: Hospira Inc. on Tuesday said it will acquire Orchid Chemicals and Pharmaceuticals Ltd’s generic injectable finished dosage form pharmaceuticals business for approximately $400 million (Rs1,864 crore). The acquisition includes Orchid’s beta-lactam antibiotics manufacturing complex and pharmaceutical research and development facility at Irungattukottai, Chennai, as well as its generic injectable product portfolio and pipeline.

Close